Position in ARDX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$4,197,688
-$18,320 QoQ
Shares Held
700,783
-3.1% QoQ
Ownership
0.284%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in ARDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $4,203,063,863 across 270 Biotechnology names. ARDX ranks #98 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,586,427 | $708,403,098 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
765,411 | $591,387,145 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,679,371 | $317,485,079 | |
| 4 | INSM |
INSMED Inc
|
1,262,749 | $206,484,708 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
491,200 | $162,523,337 | |
| 6 | INCY |
Incyte Corp
|
989,709 | $93,151,403 | |
| 7 | TECH |
BIO-TECHNE Corp
|
1,759,119 | $91,931,549 | |
| 8 | MRNA |
Moderna, Inc.
|
1,691,205 | $85,913,207 |
All Filings in ARDX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,197,688 | 700,783 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $4,216,008 | 723,158 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $4,074,027 | 739,388 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $2,842,644 | 725,165 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $3,489,029 | 710,597 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $3,624,937 | 714,978 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $4,936,751 | 716,510 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $6,749,915 | 910,920 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $7,050,068 | 965,763 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $6,547,825 | 1,056,101 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $3,978,044 | 975,011 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $3,555,295 | 1,048,760 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $1,732,480 | 361,687 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $1,029,257 | 361,143 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $432,343 | 363,314 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $185,719 | 314,779 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $588,302 | 549,816 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $334,035 | 303,669 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $394,408 | 298,795 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $1,939,713 | 255,899 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $1,902,223 | 287,345 | Shares | Defined | 2021-05-13 | |
| 2020-09-30 | $1,537,184 | 292,797 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $2,046,035 | 295,670 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $1,379,629 | 242,679 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||